Context sidebar

Information

Latest News

 

Show all Announcements

22.08.2022

HPC – Medesedan ad us. vet., Injektionslösung / HPC – Equisedan ad us. vet., Injektionslösung

Zusätzliche unerwünschte Arzneimittelwirkung

15.07.2022

Batch recall – Xylasin 2% ad us. vet., Injektionslösung 25 ml und 50 ml

Rückruf der Chargen 20K212, 19J214, 20F271, 20L115 und 21B083 bis auf Stufe Detailhandel

01.07.2022

Revision of the Therapeutic Products Licensing Requirements Ordinance

Update to Annex 7 TPLRO

01.06.2022

Changes to guidance document Authorisation of human medicinal product with known active substance HMV4

ZL101_00_007e_WL

23.03.2022

Changes to the guidance document Formal requirements HMV4 and the form Import of a medicinal product according to Art. 14 (2) TPA (parallel import) HMV4

ZL_00_020e_WL / ZL106_00_002e_FO

Publications

Rückblick TAM-Vigilance 2017 (PDF, 370 kB, 07.02.2019)

Top of page